Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scholar Rock Holding (SRRK) Other Non-Current Liabilities (2017 - 2021)

Scholar Rock Holding's quarterly Other Non-Current Liabilities came in at $3000.0 in Q2 2021, down 25.0% quarter-over-quarter from $4000.0 in Q1 2021.

Scholar Rock Holding has reported Other Non-Current Liabilities for 4 years, with the latest figure at $3000.0 in Q2 2021.

  • For the quarter ending Q2 2021, Other Non-Current Liabilities changed N/A year-over-year to $3000.0; the trailing twelve-month figure through Jun 2021 stood at $3000.0 (changed N/A YoY), and the FY2020 full-year result was $5000.0, down 44.44% from the prior year.
  • Other Non-Current Liabilities for Q2 2021 stood at $3000.0, down from $4000.0 in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $37000.0 in Q4 2017, with the low at $3000.0 in Q2 2021.
  • Average Other Non-Current Liabilities over 4 years is $11600.0, with a median of $5000.0 recorded in 2020.
  • Peak annual rise in Other Non-Current Liabilities reached 44.44% in 2020, while the deepest fall reached 44.44% in 2020.
  • Tracing SRRK's Other Non-Current Liabilities over 4 years: stood at $37000.0 in 2017, then tumbled by 75.68% to $9000.0 in 2019, then sank by 44.44% to $5000.0 in 2020, then sank by 40.0% to $3000.0 in 2021.
  • The last three Other Non-Current Liabilities figures came in at $3000.0 (Q2 2021), $4000.0 (Q1 2021), and $5000.0 (Q4 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Scholar Rock Holding 500.61 Mn 20.67 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2021 3,000.00
Mar 31, 2021 4,000.00
Dec 31, 2020 5,000.00
Dec 31, 2019 9,000.00
Dec 31, 2017 37,000.00